My watch list
my.bionity.com  
Login  

3,557 Current news from the ressort products

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

BioMed X completes Alzheimer’s disease research project

29-Oct-2019

BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease. BioMed X received a milestone payment and the results of the project were transferred to AbbVie. The BioMed X team ...

more

image description
Using algorithms to track down cancer

08-Aug-2019

Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of the ...

more

Nordic Nanovector: European Patent Granted for Betalutin or Humalutin in Combination With Anti-CD20 Antibodies for Treating NHL

04-Jun-2019

Nordic Nanovector ASA announces that the European Patent Organisation (EPO) has granted the company's European Patent covering the use of Betalutin® or Humalutin® in combination with anti-CD20 antibodies for the treatment of non-Hodgkin's lymphoma (NHL). The same patent has also been issued in ...

more

Merck and Pfizer receive FDA approval for kidney cancer therapy

BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

15-May-2019

Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of patients with advanced renal cell carcinoma (RCC). This is the first FDA approval for an anti-PD-L1 therapy as part of a ...

more

image description
Development of an Efficient Enantioselective Desymmetrization Strategy Using Recombinant Pig Liver Esterases

14-May-2019

An economically significant process intensification for the efficient enzymatic synthesis of (1S,2R)-1-(methoxycarbonyl) cyclohex-4-ene-2-carboxylic acid was achieved by a careful adaption of the reaction mode to minimize mass transfer limitations. (1S,2R)-1-(methoxycarbonyl) ...

more

Alzheimer therapy passes another important test

Drug candidate PRI-002 has successfully completed Phase I of clinical research

14-May-2019

The Alzheimer drug candidate PRI-002 developed at Forschungszentrum Jülich has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks, the active substance proved to be safe for use in humans. The next milestone will ...

more

image description
Fraunhofer presents high-speed microscope with intuitive gesture control

25-Apr-2019

The Fraunhofer Institute for Production Technology IPT in Aachen has developed a high-speed microscope for quality control of large-area objects for the semiconductor and electronics industries or for rapid testing of biological samples. The microscope digitizes samples with up to 500 frames per ...

more

MorphoSys received a milestone payment from Janssen

Janssen has Expanded Clinical Development of Guselkumab into Familial Adenomatous Polyposis

17-Apr-2019

MorphoSys AG announced that its licensee Janssen Research & Development, LLC, has further expanded the clinical development of guselkumab (Tremfya(R)) into familial adenomatous polyposis (FAP), a disease of the gastrointestinal tract. Janssen has initiated a phase 1b proof-of-concept clinical ...

more

image description
Are Drones Coming to Life Science Labs?

Are You Ready for Lab Samples to be Delivered by Drones?

02-Apr-2019

Hudson Robotics, Inc. announced a collaboration with Physical Sciences Inc. (PSI) to bring drone technology to life science laboratories for sample handling. Specifically, microplates containing samples or reagents will be delivered directly to instruments and automated workcells to perform ...

more

Merck cooperates with French start-up

Generative modelling AI technology enables rapid and cost-effective design of novel drugs

15-Mar-2019

Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how we aim to ...

more

Page 1 From 356
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE